Martrine Suppository 50mg | Natural Matrine Gynecological Anti-Inflammatory

Martrine Suppository 50mg: What the Published Guidance Says

The obstetric emergency medicines and newborn-care antiseptics that sit on the WHO Model List — supplied with the labelling discipline these products demand.

Martrine Suppository 50mg sits in the Maternal & Newborn range. The notes below are the ones that most often change a specification, a label or a tender submission.

• Chlorhexidine for umbilical cord care is an EMLca medicine Section 22.7 of the Model List carries chlorhexidine 7.1% digluconate solution or gel — delivering 4% chlorhexidine — for umbilical cord care, added in 2013. MSF specifies a 3 g gel applied once daily for seven days to the tip, stump and base of the cord. WHO eEML — Chlorhexidine (umbilical cord care)
• MSF's own warning: check the ampoule strength Because magnesium sulfate is supplied in several strengths, MSF explicitly instructs users to check the strength of the ampoule carefully before use, noting that 1 g ampoules exist alongside the 5 g presentation it describes. MSF Essential Drugs — Magnesium sulfate injectable
• The protocol, and why presentation matters MSF describes two protocols: an intravenous/intramuscular schedule of 4 g by IV infusion over 15–20 minutes, then 10 g intramuscularly, then 5 g IM every four hours; and an IV-only schedule of 4 g over 15–20 minutes followed by 1 g per hour. Treatment continues for 24 hours after delivery or the last seizure. MSF Essential Drugs — Magnesium sulfate injectable

These points are quoted because they shape how Martrine Suppository 50mg is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Ordering Parameters for Martrine Suppository 50mg

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Metronidazole Suppository 500mg, Chlorhexidine Acetate Suppository 20mg, Erythromycin Suppositories 100mg, Progesterone Suppository 25mg, Clotrimazole Vaginal Suppositories 150mg, hCG Injection 5000 IU, Magnesium Sulphate BP 10% 10mL.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Martrine Suppository 50mg is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)
• Testing for heavy metals and elemental impurities

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

• Pack size: Individually sealed suppositories (blister or foil pouch); typically 7 or 10 suppositories per box. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store in a cool place (below 25°C), protected from light. Keep away from heat. Keep suppositories in their sealed packaging until use..
• Shelf life: 36 months (unopened, when stored as directed). Stability data for the marketed pack is included in the dossier.
• Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
• Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
• Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
• Batch manufacturing and packaging records released for inspection on request during supplier audits.
• Re-test or renewal support when the marketing authorisation comes up for variation or renewal.

This page describes Martrine Suppository 50mg as a product of the obstetric and newborn-care medicines named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Products Commonly Ordered with Martrine Suppository 50mg

• Metronidazole Suppository 500mg — 500mg
• Chlorhexidine Acetate Suppository 20mg — 20mg
• Erythromycin Suppositories 100mg — 100mg
• Progesterone Suppository 25mg — 25mg
• Clotrimazole Vaginal Suppositories 150mg — 150mg
• hCG Injection 5000 IU — 5000IU

Browse the full Maternal & Newborn range; all Suppositories; the complete product catalogue.